1. The metabolic changes in the hippocampus of an atherosclerotic rat model and the regulation of aerobic training
    Beibei Liu et al, 2020, Metabolic Brain Disease CrossRef
  2. fHER2, PR, ER, Ki-67 and Cytokeratin 5/6 Expression in Benign Feline Mammary Lesions
    Maria Soares et al, 2022, Animals CrossRef
  3. Estradiol Regulates Txnip and Prevents Intermittent Hypoxia-Induced Vascular Injury
    Xiao Fei Lan et al, 2017, Scientific Reports CrossRef
  4. How Lineage Tracing Studies Can Unveil Tumor Heterogeneity in Breast Cancer
    Elena Vinuesa-Pitarch et al, 2021, Biomedicines CrossRef
  5. Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling
    GUI'E XIE et al, 2016, Oncology Letters CrossRef
  6. Oestrogen receptor negativity in breast cancer: a cause or consequence?
    Vijaya Narasihma Reddy Gajulapalli et al, 2016, Bioscience Reports CrossRef
  7. Knockdown of flotillin-2 impairs the proliferation of breast cancer cells through modulation of Akt/FOXO signaling
    GUI’E XIE et al, 2015, Oncology Reports CrossRef
  8. Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor
    Daniela R. Montagna et al, 2022, BMC Cancer CrossRef
  9. Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation
    Paula Chiarella et al, 2018, Frontiers in Oncology CrossRef
  10. Black rice-derived anthocyanins inhibit HER-2-positive breast cancer epithelial-mesenchymal transition-mediated metastasis in�vitro by suppressing FAK signaling
    Jie Zhou et al, 2017, International Journal of Molecular Medicine CrossRef
  11. Smart biomaterials for enhancing cancer therapy by overcoming tumor hypoxia: a review
    Samar A. Salim et al, 2022, RSC Advances CrossRef
  12. Targeting Breast Cancer with N-Acetyl-D-Glucosamine: Integrating Machine Learning and Cellular Assays for Promising Results
    Ömür Baysal et al, 2024, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  13. Animal models for exploring the pharmacokinetics of breast cancer therapies
    Omar M Rashid et al, 2015, Expert Opinion on Drug Metabolism & Toxicology CrossRef
  14. Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells
    Afnan H. El-Gowily et al, 2021, Pharmaceuticals CrossRef
  15. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis
    Aadya Nagpal et al, 2019, Breast Cancer Research CrossRef